Royal Biologics Acquires FIBRINET Platelet-Rich Fibrin Matrix

Royal Biologics FIBRINET

Royal Biologics acquired the FIBRINET system from Vertical Spine. This furthers Royal Biologics’ strategic initiative to add novel technologies to its portfolio of autologous and live cellular solutions to support orthopedic and spinal fusion. The company received funding in 2019 to support employee onboarding, operational growth, product...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us